Personalized and Precision Medicine Journal

Abstract Cancer, the second foremost worldwide cause of mortality, affects individuals both physically and emotionally. Traditional therapies, including surgery, chemotherapy, and radiation, have detrimental consequences, necessitating the pursuit of more targeted methods. Precision medicine facilitates more tailored therapies. The introduction of next-generation sequencing technology, as well as the growing frequency of large-scale tumor molecular profiling programs throughout the world, have changed cancer diagnosis and treatment. With the increasing availability of comprehensive genetic tests in medical and scientific settings, healthcare practitioners face complex hurdles in understanding and translating data. The article encapsulates the existing and forthcoming strategies for the implementation of precision cancer therapy, emphasizing the obstacles and potential ways to enhance the understanding and optimize the therapeutic value of molecular profiling outcomes.